Logo image of 1IRBT.MI

IROBOT CORP (1IRBT.MI) Stock Fundamental Analysis

BIT:1IRBT - Euronext Milan - US4627261005 - Common Stock - Currency: EUR

3.072  +0.1 (+3.47%)

Fundamental Rating

1

1IRBT gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 33 industry peers in the Household Durables industry. 1IRBT has a bad profitability rating. Also its financial health evaluation is rather negative. 1IRBT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year 1IRBT has reported negative net income.
1IRBT had a negative operating cash flow in the past year.
In multiple years 1IRBT reported negative net income over the last 5 years.
In multiple years 1IRBT reported negative operating cash flow during the last 5 years.
1IRBT.MI Yearly Net Income VS EBIT VS OCF VS FCF1IRBT.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M -200M -300M

1.2 Ratios

1IRBT's Return On Assets of -19.70% is on the low side compared to the rest of the industry. 1IRBT is outperformed by 90.91% of its industry peers.
1IRBT has a Return On Equity of -87.91%. This is amonst the worse of the industry: 1IRBT underperforms 90.91% of its industry peers.
Industry RankSector Rank
ROA -19.7%
ROE -87.91%
ROIC N/A
ROA(3y)-24.41%
ROA(5y)-10.32%
ROE(3y)-70.34%
ROE(5y)-35.93%
ROIC(3y)N/A
ROIC(5y)N/A
1IRBT.MI Yearly ROA, ROE, ROIC1IRBT.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150

1.3 Margins

1IRBT has a Gross Margin of 22.52%. This is in the lower half of the industry: 1IRBT underperforms 75.76% of its industry peers.
In the last couple of years the Gross Margin of 1IRBT has declined.
The Profit Margin and Operating Margin are not available for 1IRBT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.24%
GM growth 5Y-15.4%
1IRBT.MI Yearly Profit, Operating, Gross Margins1IRBT.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

More info and screens

1

2. Health

2.1 Basic Checks

1IRBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for 1IRBT has been increased compared to 1 year ago.
1IRBT has more shares outstanding than it did 5 years ago.
1IRBT has a worse debt/assets ratio than last year.
1IRBT.MI Yearly Shares Outstanding1IRBT.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
1IRBT.MI Yearly Total Debt VS Total Assets1IRBT.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 0.87, we must say that 1IRBT is in the distress zone and has some risk of bankruptcy.
1IRBT has a worse Altman-Z score (0.87) than 81.82% of its industry peers.
A Debt/Equity ratio of 1.24 is on the high side and indicates that 1IRBT has dependencies on debt financing.
With a Debt to Equity ratio value of 1.24, 1IRBT is not doing good in the industry: 84.85% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF N/A
Altman-Z 0.87
ROIC/WACCN/A
WACC9.38%
1IRBT.MI Yearly LT Debt VS Equity VS FCF1IRBT.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

2.3 Liquidity

1IRBT has a Current Ratio of 1.45. This is a normal value and indicates that 1IRBT is financially healthy and should not expect problems in meeting its short term obligations.
1IRBT has a Current ratio of 1.45. This is comparable to the rest of the industry: 1IRBT outperforms 48.48% of its industry peers.
A Quick Ratio of 0.94 indicates that 1IRBT may have some problems paying its short term obligations.
1IRBT has a Quick ratio of 0.94. This is comparable to the rest of the industry: 1IRBT outperforms 54.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 0.94
1IRBT.MI Yearly Current Assets VS Current Liabilites1IRBT.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

More info and screens

2

3. Growth

3.1 Past

1IRBT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.94%, which is quite impressive.
1IRBT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.14%.
The Revenue has been decreasing by -4.01% on average over the past years.
EPS 1Y (TTM)28.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%101.06%
Revenue 1Y (TTM)-13.14%
Revenue growth 3Y-14.61%
Revenue growth 5Y-4.01%
Sales Q2Q%3.89%

3.2 Future

The Earnings Per Share is expected to grow by 22.64% on average over the next years. This is a very strong growth
Based on estimates for the next years, 1IRBT will show a decrease in Revenue. The Revenue will decrease by -0.06% on average per year.
EPS Next Y39.17%
EPS Next 2Y35.59%
EPS Next 3Y22.64%
EPS Next 5YN/A
Revenue Next Year-17.33%
Revenue Next 2Y-9.11%
Revenue Next 3Y-0.06%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1IRBT.MI Yearly Revenue VS Estimates1IRBT.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
1IRBT.MI Yearly EPS VS Estimates1IRBT.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 4 -4 -6 -8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

1IRBT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year 1IRBT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
1IRBT.MI Price Earnings VS Forward Price Earnings1IRBT.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
1IRBT.MI Per share data1IRBT.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

A more expensive valuation may be justified as 1IRBT's earnings are expected to grow with 22.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.59%
EPS Next 3Y22.64%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for 1IRBT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IROBOT CORP

BIT:1IRBT (5/28/2025, 7:00:00 PM)

3.072

+0.1 (+3.47%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)01-27 2025-01-27/amc
Earnings (Next)03-12 2025-03-12/amc
Inst Owners59.66%
Inst Owner ChangeN/A
Ins Owners4%
Ins Owner ChangeN/A
Market Cap93.88M
Analysts47.5
Price Target10.62 (245.7%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)71.85%
Min EPS beat(2)-8.35%
Max EPS beat(2)152.06%
EPS beat(4)3
Avg EPS beat(4)46.13%
Min EPS beat(4)-8.35%
Max EPS beat(4)152.06%
EPS beat(8)4
Avg EPS beat(8)-94.64%
EPS beat(12)6
Avg EPS beat(12)-70.37%
EPS beat(16)9
Avg EPS beat(16)-12.59%
Revenue beat(2)0
Avg Revenue beat(2)-8.32%
Min Revenue beat(2)-13.17%
Max Revenue beat(2)-3.48%
Revenue beat(4)1
Avg Revenue beat(4)-4.33%
Min Revenue beat(4)-13.17%
Max Revenue beat(4)1.44%
Revenue beat(8)2
Avg Revenue beat(8)-10.23%
Revenue beat(12)2
Avg Revenue beat(12)-11.98%
Revenue beat(16)6
Avg Revenue beat(16)-7.37%
PT rev (1m)-6.7%
PT rev (3m)-6.7%
EPS NQ rev (1m)-590.52%
EPS NQ rev (3m)-590.52%
EPS NY rev (1m)-53.51%
EPS NY rev (3m)-53.51%
Revenue NQ rev (1m)-40.97%
Revenue NQ rev (3m)-40.97%
Revenue NY rev (1m)-12.19%
Revenue NY rev (3m)-12.19%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.13
P/FCF N/A
P/OCF N/A
P/B 0.71
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.62
EYN/A
EPS(NY)-1.09
Fwd EYN/A
FCF(TTM)-0.9
FCFYN/A
OCF(TTM)-0.91
OCFYN/A
SpS23.41
BVpS4.3
TBVpS-0.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.7%
ROE -87.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.52%
FCFM N/A
ROA(3y)-24.41%
ROA(5y)-10.32%
ROE(3y)-70.34%
ROE(5y)-35.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.24%
GM growth 5Y-15.4%
F-Score3
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.42%
Cap/Sales 0.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.45
Quick Ratio 0.94
Altman-Z 0.87
F-Score3
WACC9.38%
ROIC/WACCN/A
Cap/Depr(3y)41.4%
Cap/Depr(5y)61.98%
Cap/Sales(3y)1.09%
Cap/Sales(5y)1.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%101.06%
EPS Next Y39.17%
EPS Next 2Y35.59%
EPS Next 3Y22.64%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.14%
Revenue growth 3Y-14.61%
Revenue growth 5Y-4.01%
Sales Q2Q%3.89%
Revenue Next Year-17.33%
Revenue Next 2Y-9.11%
Revenue Next 3Y-0.06%
Revenue Next 5YN/A
EBIT growth 1Y76.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year63.83%
EBIT Next 3Y24.01%
EBIT Next 5YN/A
FCF growth 1Y81.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y79.41%
OCF growth 3YN/A
OCF growth 5YN/A